| scholarly article | Q13442814 |
| P2093 | author name string | I-Hsin Lin | |
| Tz-Chong Chou | |||
| Fu-Chi Chen | |||
| Ching-Yu Shih | |||
| James-Cheng Ding | |||
| P2860 | cites work | Effect of nifedipine monotherapy on platelet aggregation in patients with untreated essential hypertension | Q70244861 |
| Peroxisome proliferator-activated receptor-gamma ligands inhibit nitric oxide synthesis in vascular smooth muscle cells | Q73901266 | ||
| Platelet activation increases with the severity of peripheral arterial disease: implications for clinical management | Q81160258 | ||
| Inhibitory effect of α-lipoic acid on platelet aggregation is mediated by PPARs | Q83579757 | ||
| IRAG mediates NO/cGMP-dependent inhibition of platelet aggregation and thrombus formation | Q24304178 | ||
| Regulation of eukaryotic phosphatidylinositol-specific phospholipase C and phospholipase D | Q28245266 | ||
| PKCalpha regulates platelet granule secretion and thrombus formation in mice | Q28505136 | ||
| Roles of the C-terminal tyrosine residues of LAT in GPVI-induced platelet activation: insights into the mechanism of PLC gamma 2 activation | Q28512827 | ||
| Endothelium-dependent vasodilator effects of peroxisome proliferator-activated receptor beta agonists via the phosphatidyl-inositol-3 kinase-Akt pathway | Q28579360 | ||
| NF-kappaB: a key role in inflammatory diseases | Q29617726 | ||
| The Concise Guide to PHARMACOLOGY 2013/14: nuclear hormone receptors | Q30486738 | ||
| Rosiglitazone via upregulation of Akt/eNOS pathways attenuates dysfunction of endothelial progenitor cells, induced by advanced glycation end products | Q33595290 | ||
| Relation of platelet and leukocyte inflammatory transcripts to body mass index in the Framingham heart study | Q34023032 | ||
| PPARgamma : a nuclear regulator of metabolism, differentiation, and cell growth | Q34311560 | ||
| InsP3R-associated cGMP Kinase Substrate Determines Inositol 1,4,5-Trisphosphate Receptor Susceptibility to Phosphoregulation by Cyclic Nucleotide-dependent Kinases | Q34333875 | ||
| New regulators of NF-kappaB in inflammation | Q34858737 | ||
| A novel role of sesamol in inhibiting NF-κB-mediated signaling in platelet activation | Q35672398 | ||
| Mechanisms of Platelet Activation and Integrin αIIβ3. | Q36015900 | ||
| Pleiotropic effects of nifedipine on atherosclerosis | Q36447385 | ||
| Enhanced nitric oxide and cyclic GMP formation plays a role in the anti-platelet activity of simvastatin | Q36510042 | ||
| PPARs and molecular mechanisms of transrepression | Q36791361 | ||
| Multifaceted roles of peroxisome proliferator-activated receptors (PPARs) at the cellular and whole organism levels | Q37788999 | ||
| NF-kappaB inhibitors impair platelet activation responses | Q38352662 | ||
| Emerging role of PPAR-β/δ in inflammatory process associated to experimental periodontitis | Q38910012 | ||
| Inhibition of IkappaB kinase and IkappaB phosphorylation by 15-deoxy-Delta(12,14)-prostaglandin J(2) in activated murine macrophages | Q39451400 | ||
| Integrin signaling: the platelet paradigm | Q41733864 | ||
| Nifedipine activates PPARgamma and exerts antioxidative action through Cu/ZnSOD independent of blood-pressure lowering in SHRSP. | Q42165264 | ||
| Nifedipine induces peroxisome proliferator-activated receptor-gamma activation in macrophages and suppresses the progression of atherosclerosis in apolipoprotein E-deficient mice | Q43052161 | ||
| Effects of nifedipine on platelet function | Q45758962 | ||
| Antiplatelet actions of statins and fibrates are mediated by PPARs | Q46158854 | ||
| The antiplatelet activity of magnolol is mediated by PPAR-β/γ. | Q54500540 | ||
| β2-Integrins and Acquired Glycoprotein IIb/IIIa (GPIIb/IIIa) Receptors Cooperate in NF-κB Activation of Human Neutrophils | Q56982032 | ||
| Lack of evidence for voltage dependent calcium channels on platelets | Q69381627 | ||
| The effects of nifedipine on platelet aggregation and plasma 6-keto-PGF1 alpha, and its interaction with indomethacin | Q69928393 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nifedipine | Q39111 |
| NF-κB | Q411114 | ||
| P304 | page(s) | 1490-1500 | |
| P577 | publication date | 2014-03-01 | |
| P1433 | published in | British Journal of Pharmacology | Q919631 |
| P1476 | title | Antiplatelet activity of nifedipine is mediated by inhibition of NF-κB activation caused by enhancement of PPAR-β/-γ activity | |
| P478 | volume | 171 |
| Q39200522 | Antiplatelet activity of drugs used in hypertension, dyslipidemia and diabetes: Additional benefit in cardiovascular diseases prevention. |
| Q38384163 | Antiplatelet treatment in essential hypertension: where do we stand? |
| Q35602333 | Mechanisms of Nifedipine-Downregulated CD40L/sCD40L Signaling in Collagen Stimulated Human Platelets |
| Q42592882 | New mechanisms of antiplatelet activity of nifedipine, an L-type calcium channel blocker |
| Q91841855 | Oral short-acting antihypertensive medications and the occurrence of stroke: a nationwide case-crossover study |
| Q92959413 | Role of NF-κB in Platelet Function |
Search more.